Head & Neck

PD-L1
Pembrolizumab

1st line advanced or metastatic HNSCC – with or without platinum 5FU
PD-L1 testing: companion - CPS ≥1% 

EnVision FLEX visualization system on Autostainer Link 48
HNSCC interpretation guide